The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 28, 2020
Filed:
Sep. 26, 2018
Applicant:
Cedars-sinai Medical Center, Los Angeles, CA (US);
Inventors:
Michele Tagliati, Pacific Palisades, CA (US);
Gennaro Pagano, Naples, IT;
Assignee:
Cedars-Sinai Medical Center, Los Angeles, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 31/138 (2006.01); A61K 31/167 (2006.01); A61K 31/198 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61B 6/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/138 (2013.01); A61K 31/167 (2013.01); A61K 31/198 (2013.01); A61K 31/403 (2013.01); A61K 31/404 (2013.01); A61K 45/06 (2013.01); A61B 6/507 (2013.01);
Abstract
The present disclosure teaches methods for treating and preventing a variety of neurodegenerative conditions and symptoms associated therewith, including Alzheimer's disease (AD) and idiopathic Parkinson's disease (iPD), by utilizing adrenoceptor antagonists. Adrenoceptor antagonists that can be used include β-blockers, such as acebutolol, betaxolol, bisopropolol, bopindolol, carvedilol, metoprolol, oxprenolol, propranolol, and timolol. The present disclosure also teaches methods for diagnosing and monitoring the progression of iPD.